Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition.
Masum RahmanIan OlsonMoustafa MansourLucas P CarlstromRujapope SutiwisesakRehan SaberKarishma RajaniArthur E WarringtonAdam HowardMark SchroederSisi ChenPaul A DeckerEliot F SananikoneYi ZhuTamar TchkoniaIan F ParneySandeep BurmaDesmond A BrownMoses RodriguezJann N SarkariaJames L KirklandTerry C BurnsPublished in: Molecular cancer research : MCR (2022)
These findings imply that molecularly heterogeneous GBM lines share selective senescence-induced BCL-XL dependency increase the significance and translational relevance of the senolytic therapy for latent glioma.